Biologically Active Volume of Disease (BaVD) Predicts for Survival in Metastatic Non-Small Cell Lung Cancer. Du D, Abuali T, Ladbury CJ, Liu JR, et al. Int J Radiat Oncol Biol Phys 2021;111.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Du D, Abuali T, Ladbury CJ, Liu JR, et al. Biologically Active Volume of Disease (BaVD) Predicts for Survival in Metastatic Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 2021;111.
PMID: 34701427